Evaluation of Daughter Radionuclide Release from the 103Pd/103mRh In Vivo Generator for Targeted Auger Therapy
Open Access
- 11 January 2026
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (1) , 126
Abstract
Background/Objectives: The 103Pd/103mRh in vivo generator represents a promising Auger electron-emitting system, in which both parent and daughter radionuclides emit predominantly Auger electrons with minimal accompanying radiation. This study investigates the release dynamics of daughter radionuclides from the 103Pd/103mRh in vivo generator and evaluates the underlying mechanisms governing bond rupture and daughter retention. Methods: Cyclotron irradiation of rhodium foils was performed in two separate batches, followed by radionuclide separation using conventional wet chemistry and a novel dry distillation technique. The purified 103Pd radionuclide was used to radiolabel DOTA-TATE, phthalocyanine-TATE, and DOTA-TOC chelators. The resulting complexes were immobilized on Strata-X and Strata-C18 solid-phase extraction columns. Scheduled elution experiments were conducted to quantify the release of the 103mRh daughter radionuclide. Results: The measured 103mRh release rates were 9.8 ± 3.0% and 9.6 ± 2.7% from Strata-X columns with DOTA-TATE and phthalocyanine-TATE, respectively, and 10.5 ± 2.7% and 12.0 ± 0.5% from Strata-X and Strata-C18 columns, respectively, with DOTA-TOC. These values are significantly lower than the ~100% release predicted based on the reported Auger electron yield of 186%. One explanation for this difference could be potential inconsistencies in decay data that may require correction; this needs further investigation. The results further demonstrated that delocalized π-electrons, introduced via phthalocyanine-based chelation, did not mitigate daughter release. Conclusions: The low observed daughter nuclide release represents a favorable characteristic for the future clinical translation of the 103Pd/103mRh Auger emitter pair. The findings support the conclusion that Auger electron cascades, rather than nuclear recoil energy, dominate bond rupture processes.Keywords
Funding Information
- National Research, Development and Innovation Fund of the Ministry (TKP2021-NKTA-42)
- Hungarian Government and the Chemical Doctoral School of the University of Debrecen, Hungary
This publication has 33 references indexed in Scilit:
- Verification of the accuracy of a compact beam energy monitorNuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment, 2025
- DNA single-strand break repair and human genetic diseaseTrends in Cell Biology, 2022
- Upgrade of recommended nuclear cross section data base for production of therapeutic radionuclidesJournal of Radioanalytical and Nuclear Chemistry, 2022
- PSMA: a game changer in the diagnosis and treatment of advanced prostate cancerMedical Oncology, 2021
- Recovery of platinum, palladium and rhodium from acidic chloride leach solution using ion exchange resinsHydrometallurgy, 2015
- Recoil and conversion electron implications to be taken into account in the design of therapeutic radiopharmaceuticals utilising in vivo generatorsJournal of Labelled Compounds and Radiopharmaceuticals, 2012
- Recoil effect on β-decaying in vivo generators, interpreted for 103Pd/103mRhApplied Radiation and Isotopes, 2009
- A possible in vivo generator 103Pd/103mRh—Recoil considerationsApplied Radiation and Isotopes, 2008
- An experimental comparison of the K- and L-Auger electron spectra generated in the decays of 140Nd and 111InApplied Radiation and Isotopes, 2005
- Targetry and radiochemical methods for the simultaneous cyclotron production of no-carrier-added radiopharmaceutical-quality 100Pd, 97Ru and 101mRhInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1987